ELEVANCE HEALTH INC (A58.DE) Stock Price & Overview

FRA:A58 • US0367521038

Current stock price

270.6 EUR
0 (0%)
Last:

The current stock price of A58.DE is 270.6 EUR. Today A58.DE is down by 0%. In the past month the price increased by 0.33%.

A58.DE Key Statistics

1-Month Range242.6 - 275.5
Current A58.DE stock price positioned within its 1-month range.
Market Cap
59.721B
P/E
10.48
Fwd P/E
12.09
EPS (TTM)
25.82
Dividend Yield
2.40%

A58.DE Stock Performance

Today
0%
1 Week
+5.87%
1 Month
+0.33%
3 Months
-15.67%
Longer-term
6 Months -11.19%
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

A58.DE Stock Chart

ELEVANCE HEALTH INC / A58 Daily stock chart

A58.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to A58.DE.


Chartmill TA Rating
Chartmill Setup Rating

A58.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to A58.DE. A58.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

A58.DE Earnings

On January 28, 2026 A58.DE reported an EPS of 3.33 and a revenue of 49.31B. The company beat EPS expectations (6.46% surprise) and missed revenue expectations (-2% surprise).

Next Earnings DateApr 22, 2026
Last Earnings DateJan 28, 2026
PeriodQ4 / 2025
EPS Reported$3.33
Revenue Reported49.311B
EPS Surprise 6.46%
Revenue Surprise -2.00%

A58.DE Forecast & Estimates

28 analysts have analysed A58.DE and the average price target is 338.62 EUR. This implies a price increase of 25.14% is expected in the next year compared to the current price of 270.6.

For the next year, analysts expect an EPS growth of -13.31% and a revenue growth -2.72% for A58.DE


Analysts
Analysts74.29
Price Target338.62 (25.14%)
EPS Next Y-13.31%
Revenue Next Year-2.72%

A58.DE Groups

Sector & Classification

Index Membership

A58.DE Financial Highlights

Over the last trailing twelve months A58.DE reported a non-GAAP Earnings per Share(EPS) of 25.82. The EPS decreased by -8.49% compared to the year before.


Income Statements
Revenue(TTM)199.13B
Net Income(TTM)5.66B
Industry RankSector Rank
PM (TTM) 2.84%
ROA 4.66%
ROE 12.9%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%-13.28%
Sales Q2Q%8.51%
EPS 1Y (TTM)-8.49%
Revenue 1Y (TTM)12.62%

A58.DE Ownership

Ownership
Inst Owners93.57%
Shares220.70M
Float220.15M
Ins Owners0.13%
Short Float %N/A
Short RatioN/A

About A58.DE

Company Profile

A58 logo image Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Company Info

IPO: 2001-10-30

ELEVANCE HEALTH INC

220 Virginia Avenue

Indianapolis INDIANA US

Employees: 96129

A58 Company Website

A58 Investor Relations

Phone: 18003311476

ELEVANCE HEALTH INC / A58.DE FAQ

Can you describe the business of ELEVANCE HEALTH INC?

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.


What is the stock price of ELEVANCE HEALTH INC today?

The current stock price of A58.DE is 270.6 EUR.


Does ELEVANCE HEALTH INC pay dividends?

ELEVANCE HEALTH INC (A58.DE) has a dividend yield of 2.4%. The yearly dividend amount is currently 5.92.


What is the ChartMill technical and fundamental rating of A58 stock?

A58.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


On which exchange is A58.DE stock listed?

A58.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the market capitalization of A58 stock?

ELEVANCE HEALTH INC (A58.DE) has a market capitalization of 59.72B EUR. This makes A58.DE a Large Cap stock.